Mediterranean Diet, Inflammation, and Premature Death Risk

A high inflammation score tracked with shorter life expectancy

Chronic inflammation is easy to talk about and hard to measure well. A single C-reactive protein (CRP) result can rise after an infection, an injury, or a strenuous workout. A large 2024 UK Biobank cohort study took a broader approach: it combined CRP, white blood cell count, platelet count, and the neutrophil-to-lymphocyte ratio (NLR) into an INFLA-Score.

Among 448,574 participants followed through February 2022, higher scores tracked with a graded increase in premature all-cause mortality. By age 60, people in the highest score quartile had an estimated life-expectancy deficit of up to four years compared with those in the lowest quartile. That is an association, not proof that inflammation itself caused every death. Still, the scale and dose-response pattern make chronic inflammatory burden a meaningful risk signal.

The score ranges from -16 to +16 and gives equal weight to decile rankings for its four components. The logic is sensible: inflammation does not announce itself through one lab value alone. The researchers also cited prior evidence in which CRP, NLR, or platelet count had poor or null independent associations with mortality after adjustment. Combining markers may capture a more stable signal than treating one blood test as a crystal ball.

But the score is not a diagnosis, and it is not a personal mortality forecast. The UK Biobank measured each marker once at baseline. Blood counts and CRP vary within a person over time, so a single draw can misclassify someone's usual inflammatory state. The score also uses equal weights rather than weights optimized and validated in an independent cohort.

Why diet enters the picture

The Mediterranean diet has the strongest observational track record among commonly discussed eating patterns for lower inflammatory biomarkers. A 2021 systematic review of observational studies found that Mediterranean-style dietary patterns were consistently associated with lower CRP and other inflammatory markers in adults. In practical terms, this pattern emphasizes vegetables, fruit, legumes, whole grains, nuts, olive oil, fish, and generally less ultra-processed food and processed meat.

Association alone leaves an awkward question: do people have lower inflammation because of the diet, or because people who maintain that diet also differ in weight, income, activity, medical care, smoking, medication use, and a long list of other variables? A PREDIMED-Plus mediation analysis offers one plausible route. It found that changes in anthropometric measures, particularly adiposity, significantly mediated the association between improved Mediterranean diet adherence plus physical activity and a better inflammatory profile.

That mechanism fits basic physiology. Visceral fat tissue produces pro-inflammatory cytokines, which can raise downstream CRP and affect blood-cell ratios. It does not prove that olive oil, walnuts, fiber, omega-3 fats, or polyphenols each independently normalize CRP, white blood cells, or NLR. The available evidence does not quantify those separate contributions in general-population cohorts.

The best causal-looking analysis still used observational data

A 2025 NHANES analysis of 33,881 Americans compared nine dietary patterns using statistical causal-inference and mediation models. It ranked the Mediterranean diet highest for cardiovascular mortality prevention and identified inflammatory pathways, including dietary inflammatory index, CRP, and IL-6 measures, as the dominant mediators.

That result strengthens the case that diet, inflammation, and cardiovascular risk belong in the same conversation. It does not turn the chain into experimentally proven causation. The investigators analyzed observational data rather than assigning people to diets in a randomized trial or using genetic instruments. Unmeasured factors that influence both food choices and health could still create part of the apparent mediation effect.

A review published in 2026 cited a 25,994-person prospective analysis with 25 years of follow-up in which the highest Mediterranean-diet adherence quintile had mean hs-CRP of 1.2 mg/L versus 2.1 mg/L in the lowest quintile, alongside 23% lower all-cause mortality. Those figures are attention-grabbing, but the underlying primary study was not directly available for evaluation here. Its design, adjustments, and funding therefore cannot be assessed, so the estimate deserves less weight than directly appraised studies.

The strongest challenge: effects may be smaller in healthy adults

The Mediterranean diet's anti-inflammatory reputation is most persuasive in people who have excess adiposity, metabolic dysfunction, or high cardiovascular risk. It is less settled in broadly healthy populations.

In the EPIC-Potsdam cohort study, researchers examined Mediterranean diet score at baseline and again 6.8 years later, then related it to long-term average hs-CRP measured twice about 8.6 years after dietary baseline. In the hs-CRP analysis of 565 participants, the estimated effects were small and statistically non-significant. The authors noted that earlier randomized-trial evidence for CRP reduction had largely come from obese or metabolically dysfunctional participants.

This finding does not establish that the diet has no effect. The hs-CRP sample of 565 and the chemerin sample of 636 came from an original cohort of 27,548 recruits, leaving limited precision for modest effects and room for a false-negative result. It does, however, put a useful limit on oversized claims: a Mediterranean diet may move inflammatory biomarkers less in metabolically healthy adults than in people with substantial visceral fat or cardiometabolic disease.

The UK Biobank analysis poses a second problem for a simple rescue narrative. Its dietary analysis included 122,112 participants who completed at least one 24-hour dietary recall, about 27% of the full cohort. Among participants with high INFLA-Scores, Mediterranean-diet adherence was associated with a hazard ratio of 1.19 for mortality, with a 95% confidence interval of 0.96 to 1.47. Because that interval includes 1.0, the analysis did not show a statistically significant attenuation of excess mortality risk.

The dietary subgroup may also have been unusually health-conscious because completing voluntary recalls is selective. That can blur differences between eating patterns. The result therefore neither proves that the diet fails nor supports the claim that it neutralizes the risk attached to a high inflammation score.

What to do with an elevated inflammatory marker

First, do not treat one elevated CRP, white blood cell count, or NLR as a longevity score. Acute infection, autoimmune disease, smoking, medication, injury, and undiagnosed illness can alter these measurements. Persistent abnormalities deserve clinical context and, when appropriate, repeat testing with a clinician. In older populations, medication use creates another complication: statins, antihypertensives, and NSAIDs can change inflammatory biomarkers independently of diet, as discussed in a 2024 Health and Retirement Study analysis.

For someone with elevated markers outside an acute illness, a Mediterranean-style diet is a reasonable dietary choice with the best support in this evidence base for improving inflammatory biomarkers. The likely payoff is greatest when the change also reduces excess visceral fat. Pairing it with physical activity makes biological and practical sense, although the PREDIMED-Plus analysis evaluated those changes together rather than isolating a diet-only effect.

Set expectations by population. The evidence supports lower inflammatory burden and lower mortality risk as linked outcomes at the population level. It supports Mediterranean eating as a pattern associated with better inflammatory profiles. It does not show that the diet can erase the mortality association of a high INFLA-Score, especially in lean, metabolically healthy adults.

Verdict: measure persistent inflammation carefully, look for medical causes, and use Mediterranean-style eating as a credible long-term dietary tool rather than a promise to cancel a high-risk lab profile.

The unanswered causal question remains substantial. No study in this group used Mendelian randomization to test whether genetically predicted inflammatory markers cause mortality, and large randomized trials in general adult populations with inflammatory-biomarker endpoints are absent. The most honest conclusion is also the most useful: inflammation is a measurable risk signal; diet may help shift it, particularly through changes in adiposity; and the size of that shift depends on who is doing the eating.